Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBDIX vs RYOIX overlap: 45% of top holdings shared

Bottom line

How much do FBDIX and RYOIX overlap?

45% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 37.3% of FBDIX's assets and 29.9% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FBDIXRYOIX
Weight overlap (top 25)45%
Shared holdings12
Weight in shared holdings37.3%29.9%
Total positions12674
Expense ratio1.01%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FBDIX and RYOIX have in common

Holding% of FBDIX% of RYOIXOverlap
Jazz Pharmaceuticals plc5.66%1.42%1.42%
Amgen, Inc.4.39%5.05%4.39%
Gilead Sciences, Inc.3.86%4.49%3.86%
Regeneron Pharmaceuticals, Inc.3.77%2.93%2.93%
Argenx SE3.62%1.48%1.48%
Vertex Pharmaceuticals, Inc.3.54%4.32%3.54%
Revolution Medicines, Inc.3.01%2.48%2.48%
Guardant Health, Inc.2.76%1.72%1.72%
Insmed, Inc.1.99%1.79%1.79%
Neurocrine Biosciences, Inc.1.82%1.52%1.52%
Bridgebio Pharma, Inc.1.67%1.38%1.38%
Cytokinetics, Inc.1.24%1.35%1.24%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBDIX

  1. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  2. Ascendis Pharma A/S — 2.56%
  3. Dianthus Therapeutics, Inc. — 2.32%
  4. Mirum Pharmaceuticals, Inc. — 1.98%
  5. Praxis Precision Medicines, Inc. — 1.91%
  6. Spyre Therapeutics, Inc. — 1.87%
  7. Oruka Therapeutics, Inc. — 1.86%
  8. PTC Therapeutics, Inc. — 1.65%
  9. AstraZeneca plc — 1.51%
  10. Franklin Institutional U.S. Government Money Market Fund — 1.45%
  11. Amylyx Pharmaceuticals, Inc. — 1.32%
  12. Eli Lilly & Co. — 1.31%
  13. Tango Therapeutics, Inc. — 1.23%

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Alnylam Pharmaceuticals Inc — 2.36%
  3. Beone Medicines Ltd — 2.17%
  4. Moderna Inc — 2.15%
  5. Biogen Inc — 2.13%
  6. Natera Inc — 2.12%
  7. Royalty Pharma Plc — 2.01%
  8. Illumina Inc — 1.94%
  9. United Therapeutics Corp — 1.72%
  10. Roivant Sciences Ltd — 1.66%
  11. Incyte Corp — 1.62%
  12. Viatris Inc — 1.55%
  13. Ionis Pharmaceuticals Inc — 1.35%

Asset mix

Asset typeFBDIXRYOIX
Stocks97.0%99.6%
Cash & short-term funds4.6%0.6%
Preferred stock1.0%—
Other0.6%—
Repurchase agreements—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFBDIXRYOIX
US82.0%85.8%
IE6.7%2.7%
NL4.5%1.5%
CH1.2%3.3%
GB1.5%3.2%
DK2.6%0.9%
FR1.7%—
BM—1.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FBDIX and RYOIX overlap?
About 45% by weight. 12 securities appear in both funds' top 25 holdings; they make up 37.3% of FBDIX's assets and 29.9% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBDIX and RYOIX have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Revolution Medicines, Inc..
Should I own both FBDIX and RYOIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBDIX or RYOIX?
FBDIX is broader, with 126 positions versus 74 for RYOIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.